FEI Tribunal issues Consent Award for failure to submit sample collection

The FEI Tribunal has issued a Consent Award under the FEI Equine Anti-Doping Rules Article 2.3 for Evading, Refusing or Failing to Submit the horse to Sample Collection.

In this case, the athlete Abdullah Aldhuwayhi (FEI ID 10203839/KSA), failed to submit the horse Shaymaa (FEI ID 106RQ41/KSA), to the doping control station for a sample collection at the CEI2* 120 - Al Ula (KSA), 03-04 March 2023.

The athlete, admitted the rule violation and accepted the consequences. In its final decision the FEI Tribunal disqualified the horse and rider combination from the event and imposed an 18-month ineligibility period on the athlete from the date of the Consent Award. He was also fined CHF 5,000.

The full Decision is available here.

Notes to Editors:

FEI Equine Prohibited Substances

The FEI Prohibited Substances List is divided into two sections: Controlled Medication and *Banned Substances. Controlled Medication substances are medications that are regularly used to treat horses, but which must have been cleared from the horse’s system by the time of competition. Banned (doping) Substances should never be found in the body of the horse and are prohibited at all times.

In the case of an adverse analytical finding (AAF) for a Banned Substance, the Person Responsible (PR) is automatically provisionally suspended from the date of notification (with the exception of certain cases involving a Prohibited Substance which is also a **Specified Substance). The horse is provisionally suspended for two months.

Information on all substances is available on the searchable FEI Equine Prohibited Substances Database.